Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

  • Konstantinos Rounis,
  • Dimitrios Makrakis,
  • Chara Papadaki,
  • Alexia Monastirioti,
  • Lambros Vamvakas,
  • Konstantinos Kalbakis,
  • Krystallia Gourlia,
  • Iordanis Xanthopoulos,
  • Ioannis Tsamardinos,
  • Dimitrios Mavroudis,
  • Sofia Agelaki

An additional affiliation is missing for the first author. Konstantinos Rounis is also affiliated with: Laboratory of Translational Oncology, Medical School, University of Crete.

Reference

  1. 1. Rounis K, Makrakis D, Papadaki C, Monastirioti A, Vamvakas L, Kalbakis K, et al. (2021) Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study. PloS ONE 16(6): e0252537. pmid:34061904

Citation: Rounis K, Makrakis D, Papadaki C, Monastirioti A, Vamvakas L, Kalbakis K, et al. (2023) Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study. PLoS ONE 18(11): e0294382. https://doi.org/10.1371/journal.pone.0294382

Published: November 9, 2023

Copyright: © 2023 Rounis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.